Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666991

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666991

Antimicrobial (Enzymatic) Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 310 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Antimicrobial Protein Hydrolysates Market for food and pet food applications amassed USD 256.2 million in 2024 and is projected to grow at a CAGR of 7.4% from 2025 to 2034. This growth is primarily driven by the increasing demand for natural, bio-based antimicrobial agents across industries such as food, pharmaceuticals, and personal care.

Antimicrobial (Enzymatic) Protein Hydrolysates Market - IMG1

As consumers become more aware of the risks associated with synthetic preservatives, enzymatic protein hydrolysates are gaining popularity due to their functional benefits, including extended shelf life and enhanced health properties. The growing concern over antimicrobial resistance is prompting industries to turn to protein-based hydrolysates, which have been shown to effectively control harmful microorganisms. Furthermore, advances in biotechnology have improved the production efficiency of these hydrolysates, increasing their availability and supporting their adoption across various sectors, including nutraceuticals and animal feed.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$256.2 Million
Forecast Value$532 Million
CAGR7.4%

The antimicrobial protein hydrolysates market is categorized by source, with the main segments being plant, animal, and microorganisms. The animal-derived segment held the largest market share in 2024, generating USD 149.9 million, and is expected to reach USD 306.9 million by 2034. Animal-based proteins, sourced from fish, milk, and eggs, are highly valued for rich amino acid profiles and bioactive peptides, which show antimicrobial features. These proteins are widely used in food preservation and medications owing to their safety and effectiveness in inhibiting the growth of harmful microorganisms.

In terms of form, the market is divided into liquid, powder, and paste categories. The powder form leads the market, accounting for 63% share in 2024. Powders are preferred due to their stability, which makes them easier to transport and handle across different industries, including food, pharmaceuticals, and cosmetics. They also offer precise dosing, allowing manufacturers better control over formulations. Additionally, powdered hydrolysates are highly adaptable, as they can be reorganized into fluids or added to dry mixes, improving their serviceability in various applications.

U.S. antimicrobial (enzymatic) protein hydrolysates market for food and pet food applications was valued at USD 57.9 million in 2024. This market is growing rapidly due to increasing consumer demand for clean-label, natural ingredients in food products. The shift away from synthetic preservatives, along with heightened concerns about antimicrobial resistance, is further driving the demand for bio-based antimicrobial solutions in both pharmaceuticals and nutraceuticals.

Product Code: 5285

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Rising demand for natural antimicrobials
      • 3.6.1.2 Antimicrobial resistance concerns
      • 3.6.1.3 Expanding applications
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 High production costs
      • 3.6.2.2 Regulatory challenges
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2034 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Plant
    • 5.2.1 Chickpea
    • 5.2.2 Soybeans
    • 5.2.3 Common beans
    • 5.2.4 Rice
    • 5.2.5 Others
  • 5.3 Animal
    • 5.3.1 Milk
    • 5.3.2 Eggs
    • 5.3.3 By-products
  • 5.4 Micro-organisms
    • 5.4.1 Algae
    • 5.4.2 Fungi
    • 5.4.3 Others

Chapter 6 Market Size and Forecast, By Form, 2021-2034 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Liquid
  • 6.3 Powder
  • 6.4 Paste

Chapter 7 Market Size and Forecast, By End Use, 2021-2034 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Food & beverage
    • 7.2.1 Culinary & functional food
    • 7.2.2 Meat
  • 7.3 Pet food

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Million) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 A Constantino & C Spa
  • 9.2 Aker Biomarine
  • 9.3 AMCO Proteins
  • 9.4 Biomega Group
  • 9.5 BRF Ingredients
  • 9.6 Cargill Incorporated
  • 9.7 Crescent Biotech
  • 9.8 IQI Petfood
  • 9.9 IsoNova Technologies
  • 9.10 Kemin Industries
  • 9.11 Kerry Group
  • 9.12 Loryma GmbH
  • 9.13 New Alliance Dye Chem
  • 9.14 Pestell Nutrition
  • 9.15 Proliver
  • 9.16 Sonac
  • 9.17 Titan Biotech
  • 9.18 Vetpharm Laboratories
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!